Skip to main content
Clinical Trials/NCT06551714
NCT06551714RecruitingNot Applicable

The Effect of Neurophysiological Facilitation Techniques on Pulmonary Function, Respiratory Muscle Strength and Functional Capacity in The Early Stage After Open Heart Surgery

Dogus Universitesi1 site in 1 country32 target enrollmentStarted: January 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
32
Locations
1
Primary Endpoint
İnspiratory muscle strength

Study Overview

Brief Summary

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery.

Do neurophysiological facilitation techniques improve individuals' respiratory parameters more than phase 1 cardiac rehabilitation?

Do neurophysiological facilitation techniques improve individuals' functional capacity more than phase 1 cardiac rehabilitation?

Researchers will apply phase 1 cardiac rehabilitation to both groups to see the effectiveness of neurophysiological facilitation techniques.

Detailed Description

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery.

The study was performed on 32 patients who underwent open heart surgery. Patients divided into two groups which study group (n=18) and control group (n=14).

Range of motion, breathing and mobilization exercises within the scope of phase 1 cardiac rehabilitation program were applied to the control group; in addition to the phase 1 cardiac rehabilitation program, neurophysiological facilitation techniques (perioral stimulation, intercostal tension, anterior basal lift, vertebral pressure, moderate manual pressure and abdominal co-contraction) were applied to the study group.

Sociodemographic features and disease-specific findings were recorded on the first postoperative day .

Vital signs, functional capacity, pulmonary function, fatigue and dyspnea of every patient were recorded before and after each treatment on the first four postoperative days.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Having open heart surgery for the first time,
  • •Being between the ages of 18-75,
  • •Being fully cooperative

Exclusion Criteria

  • •Having facial, sternum and rib fractures,
  • •Having chronic renal failure,
  • •Development of cerebrovascular accident,
  • •Having cognitive dysfunction,
  • •Development of deep vein thrombosis in the post-operative period,
  • •Having neuromuscular disease,
  • •Having an orthopedic disability,
  • •Intubation time longer than 24 hours,
  • •Staying in intensive care for more than 48 hours

Arms & Interventions

Control Group

Experimental

Phase 1 cardiac rehabilitation

Intervention: Phase 1 cardiac rehabilitation (Procedure)

Study Group

Active Comparator

Neurophysiological facilitation techniques in addition to phase 1 cardiac rehabilitation techniques

Intervention: Phase 1 cardiac rehabilitation (Procedure)

Study Group

Active Comparator

Neurophysiological facilitation techniques in addition to phase 1 cardiac rehabilitation techniques

Intervention: Neurophysiological facilitation techniques (Procedure)

Outcomes

Primary Outcomes

İnspiratory muscle strength

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Maximum Inspiratory Pressure (MIP) - pressure

Time Up and Go (TUG)

Time Frame: first day of treatment before treatment and last day of treatment after treatment, up to 3 month

The person gets up from the chair, walks 3 meters, comes back and sits on the chair. - minute

Vital sign

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Oxygen saturation

2 Minute Walk Test

Time Frame: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month

It is walking as fast as the person can for 2 minutes without any assistance, at a safe distance of 30 meters. - meter

Life quality

Time Frame: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month

The Minnesota Living with Heart Failure Questionnaire

Respiratory frequency

Time Frame: Before and after treatment on each day, up to 3 month

Number of times a person inhales and exhales in 1 minute. - number

Blood pressure

Time Frame: Before and after treatment on day of treatment, up to 3 month

Blood pressure is the pressure of blood within the arteries of the circulatory system. - pressure

Depression

Time Frame: Before treatment on the first day of treatment and after treatment on last day of treatment, up to 3 month

Beck's depression inventory

Expiratory muscle strength

Time Frame: After and before treatment on each day of treatment, up to 3 month

Maximum Expiratory Pressure (MEP) - pressure

Heart rate

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Number of times a person heart rate in 1 minute. - number

Symptom

Time Frame: Before and after treatment on each day of treatment, up to 3 month

Dyspnea

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Feyza Merakli

lecturer

Dogus Universitesi

Study Sites (1)

Loading locations...

Similar Trials

The Effect of Neurophysiological... | Clinical Trial